Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD

被引:13
|
作者
Kaspar, Georgy [1 ]
Sanam, Kumar [1 ]
Gholkar, Gunjan [1 ]
Bianco, Nicole R. [2 ]
Szymkiewicz, Steven [2 ]
Shah, Dipak [3 ]
机构
[1] Michigan State Univ, Dept Cardiol, Providence Providence Pk Hosp, Coll Human Med, Southfield, MI 48075 USA
[2] ZOLL, Pittsburgh, PA USA
[3] Michigan State Univ, Dept Cardiac Electrophysiol, Providence Providence Pk Hosp, Coll Human Med, 16001 West Nine Mile Rd, Southfield, MI 48075 USA
关键词
Implantable cardioverter-defibrillator (ICD); Sudden cardiac arrest (SCA); Cardiac device infections (CDI); Wearable cardioverter defibrillator (WCD); SUDDEN CARDIAC DEATH; ELECTRONIC DEVICE INFECTIONS; AMERICAN-HEART-ASSOCIATION; UNITED-STATES; PERMANENT PACEMAKER; RISK-FACTORS; RATES; MANAGEMENT; PREVENTION; TECHNOLOGY;
D O I
10.1016/j.ijcard.2018.08.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate the effectiveness of wearable cardioverter defibrillator (WCD) use in protecting patients from sudden cardiac arrest (SCA) while they were treated in nonhospital settings until re-implantation of an Implantable cardioverter-defibrillator (ICD) was feasible. We sought to determine whether the WCD could be successfully utilized long term (>= 1 year) after ICD extraction in patients at continued risk of SCD in which ICD reimplantation was not practical. Background: ICDs have proven to improve mortality in patients for both secondary and primary prevention of SCA. Increased ICD implantation in older patients with comorbid conditions has resulted in higher rates of cardiac device infections. Currently, a wearable cardioverter defibrillator (WCD) is an alternative management for SCA prevention in specific cases. Methods: This a retrospective analysis based on consecutive WCD patients who underwent ICD explant due to device-related infections or mechanical reasons between April 2007 and July 2014. A total of 102 patients were identified from the national database maintained by ZOLL (Pittsburgh, PA, USA). We analyzed the reason for WCD use, demographic information, device data, compliance and duration of WCD use, detected arrhythmias and therapies, and reason for discontinuing WCD use. Results: In these longterm WCD users, average length of WCD use was 638 +/- 361 days. Nine patients (8.8%) had a sustained ventricular arrhythmia that was successfully resuscitated by the WCD. Six patients (5.8%) experienced inappropriate shocks. Two patients (1.9%) died of asystole events while wearing the WCD and an additional 10 patients died while not monitored by the WCD. Thirty-nine patients (38.2%) ended WCD use when a new ICD was implanted and 15 patients (14.7%) were still wearing the WCD at the time of analysis. Conclusions: We found that extending use of the WCD to >= 1 year is a safe and effective alternative treatment for patients with explanted ICDs who are not pacemaker dependent. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 50 条
  • [41] Life with an implantable cardioverter defibrillator (ICD): patients perspective
    Varhese, S.
    Ohlow, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1227 - 1227
  • [42] Long-term complications of implantable cardioverter defibrillator with epicardial lead system in 317 patients
    Miyata, A
    Suzuki, J
    Abdullah, EE
    Lerman, RD
    Bhandari, AK
    Park, YM
    Cannom, DS
    CIRCULATION, 1998, 98 (17) : 788 - 788
  • [43] Long-term incidence of upper extremity venous obstruction in implantable cardioverter defibrillator patients
    Horlbeck, Fritz W.
    Eckerth, Christopher
    Linhart, Markus
    Schaefer, Christian
    Jakob, Mark
    Pingel, Simon
    Klarmann-Schulz, Ute
    Nickenig, Georg
    Schwab, Joerg O.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (06): : 1027 - 1032
  • [44] LONG-TERM OUTCOMES IN PATIENTS WITH AN IMPLANTED CARDIOVERTER-DEFIBRILLATOR ACCORDING TO THE KUZBASS REGISTRY
    Lebedeva, N. B.
    Talibullin, I., V
    Parfenov, P. G.
    Kashtalap, V. V.
    Barbarash, O. L.
    KARDIOLOGIYA, 2022, 62 (12) : 56 - 62
  • [45] Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator
    Waldmann, V
    Bouzeman, A.
    Duthoit, G.
    Koutbi, R.
    Bessiere, F.
    Labombarda, F.
    Marquie, C.
    Gourraud, J. B.
    Ladouceur, M.
    Mondoly, P.
    Sacher, F.
    Iserin, L.
    Thambo, J. B.
    Combes, N.
    Marijon, E.
    EUROPEAN HEART JOURNAL, 2020, 41 : 792 - 792
  • [46] Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator
    Waldmann, V.
    Bouzeman, A.
    Marquie, C.
    Labombarda, F.
    Koutbi, R.
    Sellal, J. M.
    Fauchier, L.
    Mondoly, P.
    Pasquie, J. L.
    Anselme, F.
    Eschalier, R.
    Iserin, L.
    Thambo, J. B.
    Combes, N.
    Marijon, E.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1368 - 1368
  • [47] Anxiety disorders with implanted cardioverter defibrillator (ICD) patients
    Benninghoven, D
    Kunzendorf, S
    Heberlein, I
    Jantschek, G
    PSYCHOTHERAPEUT, 2006, 51 (03): : 206 - 213
  • [48] Audit of potential Implantable Cardioverter defibrillator ICD) patients
    Plummer, CJ
    McComb, JM
    EUROPACE 2001, 2001, : 211 - 216
  • [49] Use of the wearable cardioverter-defibrillator - the Swiss experience
    Boldizsar, Kovacs
    Sven, Reek
    Christian, Sticherling
    Beat, Schaer
    Andre, Linka
    Peter, Ammann
    Roman, Brenner
    Nazmi, Krasniqi
    Andreas, Muller S.
    Omer, Dzemali
    Richard, Kobza
    Christian, Grebmer
    Laurent, Haegeli
    Jan, Berg
    Kurt, Mayer
    Jurg, Schlapfer
    Giulia, Domenichini
    Tobias, Reichlin
    Laurent, Roten
    Haran, Burri
    Urs, Eriksson
    Ardan, Saguner Ma
    Jan, Steffel
    Firat, Duru
    SWISS MEDICAL WEEKLY, 2020, 150 : w20343
  • [50] Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
    Uslu, Abdulkadir
    Dogan, Cem
    Duman, Hakan
    Tanboga, Ibrahim Halil
    Askin, Lutfu
    Sevimli, Serdar
    NORTHERN CLINICS OF ISTANBUL, 2019, 6 (01) : 40 - 47